Robert Francomano - Insider Trading & Ownership

Entity
Individual
Location
C/O Stemline Therapeutics, Inc., 750 Lexington Avenue, 11 Th Floor, New York, NY
Summary
The estimated net worth of Robert Francomano is at least $278K dollars as of January 25, 2024. Robert Francomano is the Chief Commercial Officer of SELLAS Life Sciences Group, Inc. and owns shares of SELLAS Life Sciences Group, Inc. (SLS) stock worth about $278K.
All Insider Reports
All Insider Reports

Ownership of Robert Francomano

Insider Transactions Reported by Robert Francomano:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.